Eli Lilly, Novo reportedly nearing U.S. deals for obesity drug prices (update)
Weight-loss drugmakers Eli Lilly (LLY) and Novo Nordisk (NVO) (OTCPK:NONOF) are planning to announce new drug pricing deals with the White House, including for their blockbuster obesity therapies, multiple news outlets reported on Tuesday, citing sources...
Seeking Alpha